ArticleDatabase : the journal of biological databases and curation2026
ARTS-DB 2.0: an expanded database for target-directed genome mining across bacteria and fungi.
Article in Database : the journal of biological databases and curation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The increasing prevalence of antimicrobial resistance requires efficient strategies to prioritize biosynthetic gene clusters (BGCs) that may encode bioactive compounds with new modes of action. Target-directed genome mining (TDGM) addresses this challenge by leveraging self-resistance determinants encoded within or adjacent to BGCs to generate target hypotheses and prioritize candidate clusters. ARTS and FunARTS automate TDGM for bacterial and fungal genomes by detecting resistance-associated evolutionary signals, including duplicated essential targets, atypical phylogenetic patterns, and BGC co-localization. The Antibiotic Resistant Target Seeker database (ARTS-DB) was originally developed to enable exploration of precomputed TDGM outputs for bacteria. Here, we present ARTS-DB 2.0, a major update that integrates precomputed ARTS and FunARTS results into a single cross-domain resource. ARTS-DB 2.0 contains TDGM outputs for 42 087 high-quality, non-redundant genomes (35 681 bacteria and 6406 fungi) and incorporates updated BGC annotations generated with antiSMASH 8.0 together with an expanded resistance model repertoire, including the NCBI AMR HMM catalog. The web interface supports flexible query construction and gene-centric exploration, and provides extensive cross-links to external protein, biosynthetic, and pharmacology resources (e.g. UniProt, MIBiG, ChEMBL, and DrugBank). ARTS-DB 2.0 enables rapid, large-scale investigation of resistance-associated biosynthetic patterns across bacteria and fungi, supporting resistance-aware target and BGC prioritization for natural product discovery. Database URL: https://arts-db.cs.uni-tuebingen.de/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.